Ropivacaine (Naropin, Ropivacaine Hydrochloride)
Other Medications · Approved since 1996
Description
Ropivacaine is a long-acting local anesthetic from the amide class used for perioperative pain management in colorectal cancer surgery. It provides regional anesthesia and postoperative analgesia through various delivery methods including epidural infusion, transversus abdominis plane (TAP) blocks, and rectus sheath catheters during laparoscopic and open colorectal procedures. This medication serves as a supportive care agent to optimize pain control and potentially improve surgical outcomes in CRC patients undergoing hemicolectomy, laparotomy, and other abdominal surgeries.
Mechanism of Action
Ropivacaine blocks voltage-gated sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses responsible for pain sensation. It demonstrates preferential binding to inactivated sodium channels and has reduced cardiotoxicity compared to other long-acting local anesthetics due to its S-enantiomer structure.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Naropin, Ropivacaine Hydrochloride |
| Category | Other Medications |
 Status | FDA Approved |
| Administration | IV, Epidural, Regional injection |
| Year Approved | 1996 |
| Clinical Trials | 4 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.